Strategic Global Advisors, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1580212
NEWPORT BEACH, CA
Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,221,815
-$141,621 QoQ
Shares Held
17,586
+3.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#800
of 2,266 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 40%
Shared 0%
None 60%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strategic Global Advisors, LLC holds $15,490,781 across 5 Drug Manufacturers - General names. GILD ranks #3 (14.3% of the industry book) .
All Filings in GILD
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,221,815 | 17,586 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,363,436 | 16,958 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,189,569 | 42,281 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,797,975 | 43,225 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,871,073 | 43,935 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,628,225 | 41,305 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,444,015 | 37,285 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,001,052 | 35,795 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,480,251 | 36,150 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,597,518 | 35,461 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,957,675 | 36,510 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,640,134 | 61,918 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,007,237 | 64,970 | Shares | Sole | 2023-08-14 | |
| 2020-09-30 | $2,645,638 | 41,868 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,935,953 | 38,159 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,399,486 | 45,472 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||